Suppr超能文献

通过系统的连接子衍生化实现的构象受限大环化合物作为改进的FKBP51抑制剂

Conformationally Restricted Macrocycles as Improved FKBP51 Inhibitors Enabled by Systematic Linker Derivatization.

作者信息

Spiske Moritz, Meyners Christian, Bauder Michael, Repity Maximilian, Brudy Christian, Sugiarto Wisely Oki, Achaq Hanaa, Geiger Thomas M, Hausch Felix

机构信息

Department Chemistry and Biochemistry, Clemens-Schöpf-Institute, Technical University Darmstadt Peter-Grünberg Strasse 4, 64287, Darmstadt, Germany.

present address: InfectoPharm Arzneimittel und Consilium GmbH, Von-Humboldt-Str. 1, 64646, Heppenheim, Germany.

出版信息

Angew Chem Int Ed Engl. 2025 Mar 3;64(10):e202418511. doi: 10.1002/anie.202418511. Epub 2025 Jan 21.

Abstract

Macrocycles are increasingly considered as promising modalities to target challenging intracellular proteins. However, strategies for transitioning from active linear starting points to improved macrocycles are still underdeveloped. Here we explored the derivatization of linkers as an approach for macrocycle optimization. Using the FK506-binding protein 51 (FKBP51) as a model system we prepared >140 macrocycles with systematically derivatized linkers. Two backbones were identified as promising frameworks for subsequent optimization. Surprisingly, co-crystal structure analyses revealed that these chemical templates represent an ensemble of three-dimensional (3D) conformations that can give rise to several distinct 3D-scaffolds. This resulted in a set of macrocycles with consistently improved affinity, plasma stability, and aqueous solubility compared to the linear precursors or the non-functionalized macrocycles. Our results highlight linkers as an opportunity for macrocyclic drug development, show how linker derivatization can improve the performance of macrocycles, and emphasizes the need to track macrocyclic scaffold evolution at a three-dimensional level.

摘要

大环化合物越来越被认为是靶向具有挑战性的细胞内蛋白质的有前景的药物形式。然而,从活性线性起始点过渡到改进的大环化合物的策略仍未充分开发。在这里,我们探索了连接子的衍生化作为大环化合物优化的一种方法。以FK506结合蛋白51(FKBP51)为模型系统,我们制备了140多种具有系统衍生连接子的大环化合物。确定了两个骨架作为后续优化的有前景的框架。令人惊讶的是,共晶体结构分析表明,这些化学模板代表了三维(3D)构象的集合,可产生几种不同的3D支架。与线性前体或未功能化的大环化合物相比,这产生了一组亲和力、血浆稳定性和水溶性持续提高的大环化合物。我们的结果突出了连接子作为大环药物开发的一个机会,展示了连接子衍生化如何改善大环化合物的性能,并强调了在三维水平上跟踪大环支架进化的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验